This clinical-stage biotech advancing neurological therapies reported a notable insider sale as it progresses its drug pipeline.
Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S.
This royalty-focused biotech with a broad drug portfolio reported a notable insider sale amid strong stock performance.
But what if a lesser-known candidate, from a smaller biotech company, ultimately gives both Novo Nordisk and Lilly a run for their money? Will AI create the world's first trillionaire? Our team just ...
Merck is bulking up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and plan your trading moves now.
In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil. The host of Mad ...
New stablecoin strategy fuels investor optimism.